PROSTATE-SPECIFIC ANTIGEN (PSA) - ANVISA Registration 81472060041

Access comprehensive regulatory information for PROSTATE-SPECIFIC ANTIGEN (PSA) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81472060041 and manufactured by manufacturer not specified. The registration is held by ADVAGEN BIOTECH LTDA with validity until Apr 28, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS INC., ABBOTT IRELAND DIAGNOSTIC DIVISION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.